Marco Rizzi
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies 11
- Antimicrobial Resistance in Staphylococcus 10
- HIV/AIDS drug development and treatment 9
- HIV/AIDS Research and Interventions 9
- Virology top 5%
- HIV Research and Treatment 10
- Epidemiology top 5%
- Infective Endocarditis Diagnosis and Management 11
- Neurology top 10%
- Long-Term Effects of COVID-19 8
-
- Streptococcal Infections and Treatments 6
- Co-authors
- Veronica RavasioFredy SuterMarco FalconePaolo GrossiFranco MaggioloDiego RipamontiDaniela VirgintinoMaria Bruna Pasticci
- Journals
- BMC Infectious Diseases (3 papers)Expert Review of Anti-infective Therapy (3 papers)Infection (3 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Marco Rizzi
55 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 112
- Infectious Diseases 827
- Virology 109
- Epidemiology 590
- Neurology 102
- Applied Microbiology and Biotechnology 24
Countries citing papers authored by Marco Rizzi
This map shows the geographic impact of Marco Rizzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Rizzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Rizzi more than expected).
Fields of papers citing papers by Marco Rizzi
This network shows the impact of papers produced by Marco Rizzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Rizzi. The network helps show where Marco Rizzi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marco Rizzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 18 | |
| 4 | 2021 | 110 | |
| 5 | 2018 | 28 | |
| 6 | 2017 | 25 | |
| 7 | 2016 | 4 | |
| 8 | 2015 | 7 | |
| 9 | 2014 | 19 | |
| 10 | 2014 | 71 | |
| 11 | 2014 | 0 | |
| 12 | 2014 | 7 | |
| 13 | 2013 | 24 | |
| 14 | 2011 | 1 | |
| 15 | 2011 | 21 | |
| 16 | 2010 | 63 | |
| 17 | 2005 | 29 | |
| 18 | 2002 | 63 | |
| 19 | 1995 | 1 | |
| 20 | 1994 | 5 |
About Marco Rizzi
Marco Rizzi is a scholar working on Virology, Infectious Diseases, Epidemiology, Neurology and Neurology, having authored 58 papers that have together received 1.4k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (11 papers), Infective Endocarditis Diagnosis and Management (11 papers), Antimicrobial Resistance in Staphylococcus (10 papers), HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (9 papers), HIV/AIDS Research and Interventions (9 papers), Long-Term Effects of COVID-19 (8 papers) and Streptococcal Infections and Treatments (6 papers). The work is most often cited by research in Infectious Diseases (827 citations), Virology (109 citations), Epidemiology (590 citations), Neurology (102 citations) and Applied Microbiology and Biotechnology (24 citations). Marco Rizzi has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Veronica Ravasio, Fredy Suter, Marco Falcone, Paolo Grossi, Franco Maggiolo, Diego Ripamonti, Daniela Virgintino, Maria Bruna Pasticci, Francesco Girolamo and Emanuele Durante‐Mangoni. Their work appears in journals such as BMC Infectious Diseases, Expert Review of Anti-infective Therapy, Infection, Journal of the International Association of Providers of AIDS Care (JIAPAC) and Journal of Neuropathology & Experimental Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.